A cheeky website about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. If you have a tip or want to discuss a story please feel free to email Betaville at ben@betaville.co.uk.

A wrinkle on today's BHP Billiton story in the FT

Wednesday, 11 June 2014, 4:24 pm

Good story from James Wilson over at the Financial Times today on the front page of the newspaper's Companies and Markets section. James reports BHP Billiton is looking offload all of the assets that Billiton brought to the mining giant from the historic merger of both companies in 2001...

Read more...

Fortress looks to finally get out of Gagfah

Monday, 9 June 2014, 5:51 pm

It's just hit the tape that US private equity and hedge fund manager Fortress is placing its 27pc stake in German property company Gagfah. Deutsche Bank is doing the placing for Fortress, which bought Gagfah in 2004 for £2 billion...

Read more...

Another update on the missing skyscraper story

Thursday, 5 June 2014, 11:19 pm

I see Richard Berridge has been checking out my Linked In profile. For Betaville readers that don't recall, Mr Berridge is the chief operating officer of Ryan Corporation, the company behind last year's  proposed scheme to build a 74-story residential skyscraper in Canary Wharf...

Read more...

Double basement

Tuesday, 3 June 2014, 10:53 pm

Here's a piece of advice for any hedge fund manager looking to substantially renovate their multi-million pound London pile: you are likely to irritate the other people that live in your street. ..

Read more...

Fancy a pint - part 3

Thursday, 29 May 2014, 6:38 pm

Huge hat tip to Dominic Walsh over the at The Times for his scoop on Mitchells & Butlers's "exclusive" discussions to buy the Orchid pub group for about £250m...

Read more...

Osborne begins new era

Tuesday, 20 May 2014, 2:14 am

Great to see my old colleague and sort-of boss Alistair Osborne kick off his new job at The Times with a cracking column on the Pfizer/AstraZeneca takeover situation...

Read more...

AstraZeneca rejects latest Pfizer approach

Monday, 19 May 2014, 4:33 pm

Wow - AstraZeneca has rejected Pfizer's fresh £55.00 a share offer.

Now, I have to admit I didn't see that coming. I thought the raise would allow both companies to at least start talking and get an extension to the "put up or shut up" deadline.

Indeed, one of my good sources on this story always thought this deal would deal would happen despite the public rejections from AstraZeneca and browbeating from British politicians...

Read more...

The dealmaker, the bank and the missing skyscraper

Friday, 16 May 2014, 8:22 pm

I'm not a huge fan of Canary Wharf (I used to work there when I first started on the The Daily Telegraph) but I have just stumbled across a rather interesting tale about the financial district and one of the banks based there. ..

Read more...

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].